Clinical Trials on Dysentery in Canada
Total 1 results
-
Simon BerthelotMeridian Bioscience, Inc.; Ministère de l'Économie, de la Science et de l'InnovationCompletedAcute Respiratory Infection | Acute Bacterial DiarrheaCanada
Sponsors and Collaborators
- Chengdu Integrated TCM&Western Medicine Hospital
- Meyer Children's Hospital, Florence, Italy
- Sysmex Inostics GmbH
- Intermed Hospital
- metaMe Health
- Zhengzhou First People's Hospital
- Klinikum Freising
- French National Society of Gastroenterology
- Jennifer King
- Bioraba
- Seed Health
- Kyongtae Ty Bae, M.D., Ph.D.
- CEVAC Core Lab, University Ghent
- R.Bos
- Brandeis University
- ATTRaCT program by A*STAR BMRC Singapore
- Menzis
- Creighton University
- Chul Kim
- African Institute for Health and Development
- View Full List
Medical Conditions
- Value-Based Health Insurance
- Regenerative Periodontal Treatment
- Systemic Lupus Erythematosus Nephritis
- Failure; Cardiac
- Bleeding at Gastric Cancer
- Plaque Type Psoriasis
- Adductor Pollicis
- Cell Phone Use
- Burn Wound and Skin Graft Healing
- Mild Traumatic Brain Injury; Concussion
- Bacterial Reduction Post-product Application
- Early Phase of Severe Sepsis and Septic Shock
- Chronic Hepatitis C Virus Infection
- Abdominal Aortic Aneurysm >= 5.5 Centimeters in Male (Disorder)
- Root Canal Sealers
- Hearing Loss, Bilateral or Unilateral
- Chronic Myeloid Leukemia Blast Crisis (CML-BC, Ph+)
- Alert Fatigue, Health Personnel
- Parenteral Iron Therapy
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma
- View Full List
Drug Interventions
- Plerixafor
- Acetaminophen
- Imiquimod
- Traditional Chinese Medicine
- DTG 50 mg OD with food
- Levobupivacaine + Fentanyl
- Bupivacaine-EPINEPHrine 0.5%-1:200,000 Injectable Solution
- Brisdelle (paroxetine mesylate)
- Oxytocin only
- Adverse Reactions of Gammagard subcutaneously at Week 24
- Ferric derisomaltose
- Avelumab
- Glycine
- PARCOPA
- Donepezil
- Silver diamine fluoride
- VS-6766
- Nicotine patch
- Tislelizumab
- SHR-A1921
- View Full List
CROs by country
- Contract Research Organizations in Australia
- Contract Research Organizations in Austria
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Gambia
- Contract Research Organizations in Kyrgyzstan
- Contract Research Organizations in Mali
- Contract Research Organizations in Mozambique
- Contract Research Organizations in Nigeria
- Contract Research Organizations in Paraguay
- Contract Research Organizations in Romania
- Contract Research Organizations in Sweden
- Contract Research Organizations in Zambia
- Contract Research Organizations in Zimbabwe
- CRO list by country